Literature DB >> 31483100

Activity-Based Kinome Profiling Using Chemical Proteomics and ATP Acyl Phosphates.

Caroline E Franks1, Ku-Lung Hsu1.   

Abstract

Human kinases are a large family of proteins (500+) that catalyze ATP-dependent phosphorylation of protein and metabolite substrates to regulate diverse facets of cell biology. Dysregulation and mutations of protein kinases are linked to human disease, providing opportunities for developing pharmacological agents as potential therapy. Assessing the selectivity of pharmacological compounds targeting this enzyme class is critical given that off-target activity of kinase inhibitor drugs may result in toxicity. This set of protocols outlines use of ATP acyl phosphate activity-based probes to evaluate the potency and selectivity of kinase inhibitors via fluorescent gel- and mass spectrometry-based detection methods. These competitive chemical proteomic assays can evaluate engagement of >200 native kinase targets directly in complex proteomes.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  KiNativ; activity-based protein profiling; chemical proteomics; chemoproteomics; kinase; kinome; mass spectrometry

Mesh:

Substances:

Year:  2019        PMID: 31483100     DOI: 10.1002/cpch.72

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  5 in total

1.  Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development.

Authors:  Carlos E Sanz-Rodriguez; Benjamin Hoffman; Paul J Guyett; Andrei Purmal; Baljinder Singh; Michael Pollastri; Kojo Mensa-Wilmot
Journal:  Mol Pharmacol       Date:  2022-05-23       Impact factor: 4.054

2.  Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth.

Authors:  John Victor Napoleon; Satish Sagar; Sydney P Kubica; Lidia Boghean; Smit Kour; Hannah M King; Yogesh A Sonawane; Ayrianne J Crawford; Nagsen Gautam; Smitha Kizhake; Pawel A Bialk; Eric Kmiec; Jayapal Reddy Mallareddy; Prathamesh P Patil; Sandeep Rana; Sarbjit Singh; Janani Prahlad; Paul M Grandgenett; Gloria E O Borgstahl; Gargi Ghosal; Yazen Alnouti; Michael A Hollingsworth; Prakash Radhakrishnan; Amarnath Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-27       Impact factor: 12.779

3.  Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.

Authors:  Alison M Kurimchak; Vikas Kumar; Carlos Herrera-Montávez; Katherine J Johnson; Nishi Srivastava; Karthik Davarajan; Suraj Peri; Kathy Q Cai; Gina M Mantia-Smaldone; James S Duncan
Journal:  Mol Cell Proteomics       Date:  2020-09-29       Impact factor: 5.911

4.  Reprogramming fatty acyl specificity of lipid kinases via C1 domain engineering.

Authors:  Timothy B Ware; Caroline E Franks; Mitchell E Granade; Mingxing Zhang; Kee-Beom Kim; Kwon-Sik Park; Andreas Gahlmann; Thurl E Harris; Ku-Lung Hsu
Journal:  Nat Chem Biol       Date:  2020-01-13       Impact factor: 16.174

5.  Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment.

Authors:  Shuai Ye; Dinara Sharipova; Marya Kozinova; Lilli Klug; Jimson D'Souza; Martin G Belinsky; Katherine J Johnson; Margret B Einarson; Karthik Devarajan; Yan Zhou; Samuel Litwin; Michael C Heinrich; Ronald DeMatteo; Margaret von Mehren; James S Duncan; Lori Rink
Journal:  JCI Insight       Date:  2021-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.